RESPUBLIKINIS VETERINARIJOS APRŪPINIMO CENTRAS, UAB - financials and debts
Company age: 32 y. 11 mo.
RESPUBLIKINIS VETERINARIJOS APRŪPINIMO CENTRAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,520,519 | 4,671,306 | 5,046,933 | 7,645,313 | 14,949,337 | 13,362,898 | 12,808,560 | 13,311,325 |
| Profit before tax | -88,278 | 62,338 | 250,731 | 224,661 | 409,726 | 33,564 | 268,290 | 752,211 |
| Net profit | -88,278 | 58,298 | 239,797 | 242,086 | 394,208 | 35,517 | 270,127 | 589,769 |
| Equity | 484,134 | 542,432 | 782,229 | 1,024,315 | 1,418,523 | 1,454,040 | 1,724,167 | 2,213,936 |
| Liabilities | 1,817,031 | 1,814,603 | 1,243,776 | 2,237,020 | 5,202,698 | 4,702,202 | 4,227,088 | 4,110,863 |
| Non-current assets | 27,859 | 14,108 | 8,402 | 30,488 | 882,478 | 1,596,183 | 1,736,222 | 1,200,616 |
| Current assets | 2,269,469 | 2,339,008 | 2,012,183 | 3,232,690 | 5,728,292 | 4,548,474 | 4,224,367 | 5,124,390 |
| Total assets | 2,297,328 | 2,353,116 | 2,020,585 | 3,263,178 | 6,610,770 | 6,144,657 | 5,960,589 | 6,325,006 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,151,532 | 1,964,503 | 2,394,137 |
| Social insurance contributions | - | - | - | - | - | 374,267 | 380,221 | 368,832 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +34.6% | +3.3% | +8.0% | +51.5% | +95.5% | -10.6% | -4.1% | +3.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.8% | 2.5% | 11.9% | 7.4% | 6.0% | 0.6% | 4.5% | 9.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -18.2% | 10.7% | 30.7% | 23.6% | 27.8% | 2.4% | 15.7% | 26.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2.0% | 1.2% | 4.8% | 3.2% | 2.6% | 0.3% | 2.1% | 4.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -2.0% | 1.3% | 5.0% | 2.9% | 2.7% | 0.3% | 2.1% | 5.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.8 | 3.3 | 1.6 | 2.2 | 3.7 | 3.2 | 2.5 | 1.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 253,488 | 236,522 | 235,654 | 361,195 | 454,157 | 291,025 | 274,469 | 311,984 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
RESPUBLIKINIS VETERINARIJOS APRŪPINIMO CENTRAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 1.86 |
| 2026-05-12 | 2026-05-13 | 1.86 |
| 2026-01-21 | 2026-02-12 | 0.32 |
| 2026-01-16 | 2026-01-19 | 747.22 |
| 2025-12-16 | 2025-12-21 | 1168.67 |
| 2024-11-18 | 2024-11-21 | 8.98 |
| 2024-10-24 | 2024-11-13 | 8.98 |
| 2024-07-24 | 2024-08-05 | 9.88 |
| 2024-03-18 | 2024-05-06 | 0.60 |
| 2023-12-18 | 2024-01-11 | 26.16 |
| 2023-04-18 | 2023-04-23 | 182.22 |
RESPUBLIKINIS VETERINARIJOS APRŪPINIMO CENTRAS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-30 | 2026-07-07 | 95.71 |
| 2026-06-28 | 2026-06-29 | 90651.79 |
| 2025-01-29 | 2025-02-03 | 907.0 |
| 2024-12-30 | 2025-01-22 | 129468.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
RESPUBLIKINIS VETERINARIJOS APRUPINIMO CENTRAS, UAB (code 122249763) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €13.31M and net profit of €589.8K, compared with €12.81M revenue and €270.1K net profit in 2024. This reflects a return to revenue growth and a marked improvement in profitability, with the profit margin rising to 4.4% from 2.1% a year earlier and 0.3% in 2023. Over the 2023–2025 period, revenue remained broadly stable around €13M, while net profit increased strongly. The balance sheet expanded moderately to €6.33M in assets in 2025, with equity rising to €2.21M and liabilities at €4.11M. The equity ratio was 35.0%, and debt-to-equity stood at 1.86. Asset turnover reached 2.10x, indicating efficient use of assets. Return on equity was 26.6% and return on assets 9.3%. Revenue per employee was €316.9K, with profit per employee of €14.0K.